Fresh analysis suggests that individuals who stop using popular GLP-1 drugs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who stop traditional diet and exercise programs.
Findings released in a prominent health publication points out that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month after stopping.
"People buying such drugs need to be informed of the potential of fast weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
Such speed of recovery implies a return to original weight within about 18 months.
Comparing Treatments
The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of the injectable medications with conventional dieting.
Scientists emphasize that people who lose weight through dieting usually experience a more gradual weight regain—around 0.1 kg a month—post-intervention.
Understanding the Quick Regain
Experts propose the mechanism of the injections explains the heightened rebound.
The injections mimic a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication means hunger is uncontrolled, making excessive eating a significant risk."
A Lifelong Condition?
The NHS suggest the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
Many experts argue that, given the significant potential of weight regain, the treatment should be considered life-long.
This view is reinforced by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," comparing it to managing diseases like high blood pressure.
User Testimonies
People who have come off the medication describe a powerful return of appetite.
"I experienced a switch that goes on and you're instantly starving," recalled an individual.
The struggle is worsened if users have not established lasting dietary or behavioural modifications during therapy.
Growing Use
Figures show that a significant number of adults in the UK have used these injections in the past year, with desire being substantial.
- Use is higher among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts caution that while the jabs are effective tools for weight loss, they are not a permanent solution and lasting health benefits likely depends on combined behavioural support.